These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 24767411)

  • 1. THAOS: gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease.
    Wixner J; Mundayat R; Karayal ON; Anan I; Karling P; Suhr OB;
    Orphanet J Rare Dis; 2014 Apr; 9():61. PubMed ID: 24767411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
    Coelho T; Maurer MS; Suhr OB
    Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Gentile L; Coelho T; Dispenzieri A; Conceição I; Waddington-Cruz M; Kristen A; Wixner J; Diemberger I; Gonzalez-Moreno J; Cariou E; Maurer MS; Planté-Bordeneuve V; Garcia-Pavia P; Tournev I; Gonzalez-Costello J; Duarte AG; Grogan M; Mazzeo A; Chapman D; Gupta P; Glass O; Amass L;
    Orphanet J Rare Dis; 2023 Nov; 18(1):350. PubMed ID: 37946256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).
    Maurer MS; Hanna M; Grogan M; Dispenzieri A; Witteles R; Drachman B; Judge DP; Lenihan DJ; Gottlieb SS; Shah SJ; Steidley DE; Ventura H; Murali S; Silver MA; Jacoby D; Fedson S; Hummel SL; Kristen AV; Damy T; Planté-Bordeneuve V; Coelho T; Mundayat R; Suhr OB; Waddington Cruz M; Rapezzi C;
    J Am Coll Cardiol; 2016 Jul; 68(2):161-72. PubMed ID: 27386769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal Manifestations in Hereditary Transthyretin Amyloidosis associated with Glu89Gln Mutation.
    Nakov R; Sarafov S; Nakov V; Gospodinova M; Todorov T; Kirov A; Todorova A; Tournev I
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):421-426. PubMed ID: 31826067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis.
    Wixner J; Sundström T; Karling P; Anan I; Suhr OB
    BMC Gastroenterol; 2015 Apr; 15():51. PubMed ID: 25908211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS.
    Caponetti AG; Rapezzi C; Gagliardi C; Milandri A; Dispenzieri A; Kristen AV; Wixner J; Maurer MS; Garcia-Pavia P; Tournev I; Planté-Bordeneuve V; Chapman D; Amass L;
    JACC Heart Fail; 2021 Oct; 9(10):736-746. PubMed ID: 34391735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update.
    Dispenzieri A; Coelho T; Conceição I; Waddington-Cruz M; Wixner J; Kristen AV; Rapezzi C; Planté-Bordeneuve V; Gonzalez-Moreno J; Maurer MS; Grogan M; Chapman D; Amass L;
    Orphanet J Rare Dis; 2022 Jun; 17(1):236. PubMed ID: 35717381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A natural history analysis of asymptomatic
    Coelho T; Conceição I; Waddington-Cruz M; Keohane D; Sultan MB; Chapman D; Amass L;
    Amyloid; 2022 Dec; 29(4):228-236. PubMed ID: 35730447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years.
    Wixner J; Suhr OB; Anan I
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):73-81. PubMed ID: 29073801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study.
    Inês M; Coelho T; Conceição I; Ferreira L; de Carvalho M; Costa J
    Orphanet J Rare Dis; 2020 Mar; 15(1):67. PubMed ID: 32143656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Gentile L; Diemberger I; Plante-Bordeneuve V; Mazzeo A; Dori A; Luigetti M; Di Paolantonio A; Dispenzieri A; Grogan M; Waddington Cruz M; Adams D; Inamo J; Kristen AV; Lino Cirami C; Chapman D; Gupta P; Glass O; Amass L
    PLoS One; 2024; 19(1):e0292435. PubMed ID: 38241252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal Manifestations in Hereditary Transthyretin Amyloidosis: a Single-Centre Experience.
    Luigetti M; Tortora A; Romano A; Di Paolantonio A; Guglielmino V; Bisogni G; Gasbarrini A; Calabresi P; Sabatelli M
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):339-343. PubMed ID: 32919418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis.
    Obici L; Suhr OB
    Clin Auton Res; 2019 Sep; 29(Suppl 1):55-63. PubMed ID: 31452022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transthyretin Amyloidosis with Gastrointestinal Manifestation: a Case Report.
    Nakov R; Sarafov S; Nakov V; Gospodinova M; Todorov T; Kirov A; Todorova A; Tournev I
    J Gastrointestin Liver Dis; 2019 Sep; 28(3):359-361. PubMed ID: 31517333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Waddington-Cruz M; Wixner J; Amass L; Kiszko J; Chapman D; Ando Y;
    Neurol Ther; 2021 Dec; 10(2):753-766. PubMed ID: 34024024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS).
    Cruz MW; Pinto MV; Pinto LF; Gervais R; Dias M; Perez C; Mundayat R; Ong ML; Pedrosa RC; Foguel D
    Arq Neuropsiquiatr; 2019 Feb; 77(2):96-100. PubMed ID: 30810593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.
    Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y
    J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS).
    Kristen AV; Maurer MS; Rapezzi C; Mundayat R; Suhr OB; Damy T;
    PLoS One; 2017; 12(4):e0173086. PubMed ID: 28384285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age- and Sex-Related Differences in Patients With Wild-Type Transthyretin Amyloidosis: Insights From THAOS.
    Mora-Ayestaran N; Dispenzieri A; Kristen AV; Maurer MS; Diemberger I; Drachman BM; Grogan M; Gupta P; Glass O; Amass L; Garcia-Pavia P;
    JACC Adv; 2024 Aug; 3(8):101086. PubMed ID: 39105117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.